| B9 | Serum CA-125 in the diagnosis and therapeutic monitoring of tuberculosis in HIV infected patients | E-poster | Diagnosis of co-infections and co-morbidities |
| B9 | Values & preferences on hepatitis C self-testing among populations at increased risk of HCV, healthcare workers, and the general population: a multi-country rapid qualitative assessment | E-poster | Diagnosis of co-infections and co-morbidities |
| B11 | Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study | E-poster | Tuberculosis and other mycobacteria |
| B11 | Investigating isoniazid prevention therapy completion rate among adult HIV patients on antiretroviral therapy and its effectiveness in preventing tuberculosis at Katutura Hospital, Namibia, 2014-2018 | E-poster | Tuberculosis and other mycobacteria |
| B12 | Epidemiological trends of hepatitis B morbidity and mortality in Greece, Italy, Portugal and Spain, 2000-2019: a systematic analysis from the Global Burden of Disease Study 2019 | E-poster | Viral hepatitis A, B, D and E |
| B12 | Molecular diversity of hepatitis B virus in HIV infected patients at Mbagathi District Hospital, Nairobi | E-poster | Viral hepatitis A, B, D and E |
| B13 | Clinically relevant depressive symptoms and initiation of hepatitis C virus (HCV) treatment in the HIV-HCV co-infected population in Canada | E-poster | Viral hepatitis C |
| B13 | Hepatitis C reinfection risk following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression | E-poster | Viral hepatitis C |
| B13 | Achieving an extremely high hepatitis C treatment success rate in people who inject drugs in Hai Phong, Vietnam: results of the ANRS 12380 DRIVE-C study | E-poster | Viral hepatitis C |
| B13 | The prevalence of hepatitis C virus (HCV) co-infection among people living with HIV (PLHIV) in Egypt: a cross-sectional study | E-poster | Viral hepatitis C |